School of Medicine
Showing 101-150 of 1,325 Results
-
Giselle (Ghazal) Salmasi, MD
Clinical Associate Professor, Medicine - Hematology
BioDr. Salmasi is a board-certified, fellowship-trained hematologist. She treats patients in the Hematology Program and the Hematologic Cancer Program at Stanford Health Care. Dr. Salmasi is the associate clinical chief for classical hematology. She is also a clinical associate professor in the Division of Hematology, Department of Medicine at Stanford University School of Medicine.
She treats a wide range of blood disorders and blood cancers. Her clinical/research interests include immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). Dr. Salmasi understands that patients need social and emotional support along with medical care. She founded the earliest adolescent and young adult survivorship support groups in Santa Cruz, California, and Toronto, Canada. Dr. Salmasi is also dedicated to training future doctors in providing excellent hematologic care.
Dr. Salmasi was the medical co-investigator for a national phase 3 clinical trial of endovascular therapy for treating chronic venous thrombosis.
Her research has appeared in the New England Journal of Medicine, Leukemia & Lymphoma journal and the Transfusion and Apheresis Science journal. Dr. Salmasi’s publications include articles and a chapter about lymphoma. She has also reviewed articles for the Biology of Blood and Marrow Transplantation journal and the Journal of Clinical Oncology.
Dr. Salmasi is a member of the American Society of Hematology. -
Vafi Salmasi
Assistant Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioVafi Salmasi, M.D., M.S. is an Assistant Professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine atStanford University School of Medicine. He earned his medical degree from Tehran University of Medical Sciences in 2004 and completed hisanesthesiology training at Cleveland Clinic, where he also completed a research fellowship in the Department of Outcomes Research. He subsequently joined Stanford University for fellowship training in Pain Medicine and earned a Master of Science in Clinical Research and Epidemiology from Stanford in 2019.
Dr. Salmasi's research focuses on integrating pragmatic comparative effectiveness research with clinical care in perioperative and pain medicine, supported by his NIH funding. He is an active member of the neuromodulation team at Stanford Pain Management Center, where he has established and organizes the multidisciplinary team conference for neuromodulation candidates. His clinical expertise encompasses interventional pain management with particular emphasis on neuromodulation techniques including spinal cord stimulation and peripheral nerve stimulation; and minimally invasive spine techniques including basivertebral nerve ablation and percutaneous minimally invasive lumbar decompression. -
Darren Salmi
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsCardiovascular pathology, congenital heart disease, autopsy, medical education
-
Joshua Salomon
Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies
BioJoshua Salomon is a Professor of Health Policy, a core faculty member in the Center for Health Policy, and Senior Fellow at the Freeman Spogli Institute for International Studies. His research focuses on public health policy and priority-setting, within three main substantive areas: (1) modeling patterns and trends in major causes of global mortality and disease burden; (2) evaluation of health interventions and policies; and (3) measurement and valuation of health outcomes.
Dr. Salomon is an investigator on projects funded by the Centers for Disease Control and Prevention, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost effectiveness of new health technologies.
He is Director of the Prevention Policy Modeling Lab, which is a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Prior to joining the Stanford faculty, Dr. Salomon was Professor of Global Health at Harvard T.H. Chan School of Public Health.
For more information on the Prevention Policy Modeling Lab visit ppml.stanford.edu. -
Alexander Isaac Salter
Postdoctoral Medical Fellow, Oncology
Fellow in Medicine - Med/HematologyBioI am a clinical fellow in medical oncology at Stanford University whose long-term goal is to become a translational physician-scientist who develops curative cellular immunotherapies for solid tumors. As a graduate student, I conducted the first comprehensive signaling analyses of therapeutically engineered T cells, demonstrating that signal strength, rather than quality, is a key determinant of T cell function and fate. These findings helped inform the design of next-generation cellular immunotherapies, some of which are now in clinical trials. I also co-led a collaboration with Dr. David Baker’s laboratory at the University of Washington to engineer synthetic protein “logic gates” enabling combinatorial antigen recognition with high precision, offering a potential path to more safely target solid tumors. My doctoral research resulted in 16 publications, including four prominent first-, co-first-, or second-author papers in high-impact journals, several reviews and textbook chapters, and recognition on the Forbes 30 Under 30 List.
At Stanford, I focus on translating cellular therapies for thoracic and genitourinary malignancies. Under the mentorship of Drs. Crystal Mackall and Allison Betof Warner, I am developing CAR T cells for lung cancer in non- and never-smokers and serve as a sub-investigator on an upcoming first-in-human phase 1 trial of drug-regulatable CAR T cells for adults with advanced solid tumors. -
Aaron Keith Salyapongse
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Salyapongse is a board-certified, fellowship-trained orthopaedic surgeon. He is the medical director of Interventional Services, medical director of Joint Replacement, and chief of Orthopaedics for Stanford Health Care Tri-Valley. He is also a clinical associate professor at Stanford University School of Medicine.
Dr. Salyapongse performs the full range of orthopaedic surgery procedures to treat injuries and conditions related to the hip and knee. He has extensive training and experience in the diagnosis and use of advanced treatment techniques for disorders of the hip and knee, including meniscus tears, arthritis, avascular necrosis, and post-traumatic injuries.
Dr. Salyapongse does hundreds of knee and hip replacements annually. His goal with each patient is to help them recover quickly and safely, with durable, long-lasting joint replacements as a result. He specializes in tissuesparing techniques, including an anterior approach to hip replacement.
Dr. Salyapongse is a certified instructor of anterior hip replacement. He has performed more than 2,000 procedures and traveled nationwide to teach it to other surgeons. Anterior hip replacement offers the potential for faster recovery, as it involves a small incision that presents less of a disruption to the muscles. Dr. Salyapongse also specializes in techniques such as Anterior PATH, or percutaneous assisted total hip replacements.
For knee replacements, Dr. Salyapongse uses a variety of techniques, including robotic surgery. He also specializes in partial knee replacements for patients who may be experiencing arthritis in a localized area but who might not be ready for a full replacement. Partial replacements enable patients to have a faster recovery and a more natural feeling knee post-surgery.
Dr. Salyapongse welcomes referrals from specialists as well as primary care physicians. He sees patients at every stage of their care journey, but especially when their situation has progressed beyond interim interventions like physical therapy or injections. He views each of his patients as an individual with a unique set of goals and tailors each treatment plan to fit their specific needs. While Dr. Salyapongse will help patients first explore the alternatives, he may recommend surgery once activities of daily living
(like sleep, work, or gait pattern) have been impacted.
In an effort to make outpatient care more accessible, Dr. Salyapongse has helped to pioneer the use of digital technology to prepare patients before, during, and after hip and knee surgery. His passion is to improve patient engagement and thus outcomes by letting patients know what they can expect at every stage of their care journey.
Dr. Salyapongse has co-authored articles on a variety of topics related to techniques, technologies, and outcomes in joint replacement surgery. His work has appeared in the American Journal of Orthopaedics, Journal of Arthroplasty, Current Sports Medicine Reports, and other publications.
He has made presentations on hip and knee replacement planning and surgery at meetings such as the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, and Western Orthopaedic Association.
Dr. Salyapongse has won honors for his work, such as a Physician Champion Award for outstanding patient care. He is a member of the American Academy of Hip and Knee Surgeons and the American Academy of Orthopaedic Surgeons. -
Julia Salzman
Associate Professor of Biomedical Data Science, of Biochemistry and, by courtesy, of Statistics and of Biology
Current Research and Scholarly Interestsstatistical computational biology focusing on splicing, cancer and microbes
-
Emma Samelson-Jones
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Samelson-Jones completed her medical training at UCSF in 2009, followed by psychiatry residency and a public psychiatry fellowship at the New York Psychiatric Institute / New York Presbyterian Hospital - Columbia. She served on the faculty of the UCSF Department of Psychiatry and Behavioral Sciences at UCSF from 2013 to 2026 as a clinician-educator. In 2026, she joined Stanford in as a Clinical Professor of Psychiatry and Behavioral Sciences, where she leads the Integrated Behavioral Health program with Stanford Medicine Partners at community primary care clinics.
At UCSF, Dr. Samelson-Jones was a member of the Haile T. Debas Academy of Medical Educators and the recipient of numerous teaching awards, including the Henry J. Kaiser Award for Excellence in Teaching from the UCSF School of Medicine. She developed and taught psychopharmacology courses for the senior psychiatry residents at UCSF, earning annual teaching accolades. She also co-directed the Behavioral Medicine Seminar for UC Primary Care residents (2016-24) and co-led the development of an three-year enhanced behavioral health curriculum for SF Primary Care residents (2023-26).
In 2018, Dr. Samelson-Jones was 1 of 8 physicians at UCSF to receive the Exceptional Physician Award from UCSF Health. She founded the Psychotic Experiences Clinic at UCSF to provide specialty care for patients with chronic psychosis. She also held a joint appointment in the Department of Medicine in recognition of her work within the Division of General Medicine, where she provided direct clinical consultations, launched and served as the psychiatric consultant for a collaborative care model for depression care, and supported quality improvement initiatives related to mental health care. She also trained medical students, psychiatry residents, and consult-liaison fellows in these roles. She is a frequent speaker at continuing medical education (CME) conferences for PCPs.
In 2022, Dr. Samelson-Jones received the Faculty Innovation in Teaching Award from the American Board of Psychiatry and Neurology in 2022 to create PsychSnaps (psychsnaps.com), a longitudinal medical education program designed to help primary care providers better manage their patients' mental health needs. PsychSnaps offers case-based lessons in psychiatry and addiction medicine through email newsletter and online at psychsnaps.com. PsychSnaps now has over 850 subscribers and more than 25,000 monthly unique website visitors. Dr. Samelson-Jones has authored more than 30 newsletters. The first 3 years of content have been accredited for CME as enduring materials by UCSF, and educational outcomes have been presented at national meetings. -
Jacinda Sampson
Clinical Professor, Adult Neurology
BioDr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.
-
Niyatee Samudra, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Samudra is a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She is one of a small number of neurologists nationwide who is board-certified and fellowship-trained in epilepsy as well as in behavioral neurology and neuropsychiatry.
Dr. Samudra leads a clinic at Stanford for the treatment of older adults with epilepsy. In addition, she has clinical interests in the treatment of atypical Parkinsonism and in women’s brain health across the lifespan. She co-leads the CurePSP Center of Care and is a member of the Menopause Collaborative of Practice at Stanford. Her varied research interests include clinical trials in neurodegenerative disease and in epilepsy; improving treatment for older adults with epilepsy; understanding the cognitive and neuropsychiatric consequences of epilepsy; and treatment of neuropsychiatric symptoms in neurodegenerative disorders.
Prior to coming to Stanford, Dr. Samudra was a fellow in behavioral neurology and neuropsychiatry at the University of California, San Francisco, as well as in epilepsy and clinical neurophysiology at Vanderbilt University Medical Center. She completed her undergraduate degree at MIT and obtained her medical degree and neurology residency training at the University of Texas Southwestern Medical Center.
Dr. Samudra has published in the Journal of Alzheimer’s Disease; Current Neurology and Neuroscience Reports; Journal of the Neurological Sciences; Seizure; and Epilepsy and Behavior, among others. She is a member of the American Epilepsy Society and the American Academy of Neurology. -
Stanley Samuels
Professor (Clinical) of Anesthesia, Emeritus
Current Research and Scholarly InterestsNeuroanesthesia; anesthesia in developing countries.
-
Katherine Sanborn
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr Katherine Sanborn specializes in the treatment of psychiatric inpatients. She has practiced Psychiatry for more than 15 years. Dr. Sanborn has a special interests in residency education, psychotherapy training, administration and developmental psychopathology.
-
Maria del Mar Sanchez Martin
Postdoctoral Scholar, Neurosurgery
BioI am a postdoctoral researcher in the Neurosurgery Department at Stanford University, under the supervision of Dr. Llorente. My research interests lie in novel stem cell therapies for spinal cord injury, focusing not only on therapeutic applications with translational perspectives, but also on understanding the underlying mechanisms that promote recovery
